Aprogen Biologics to issue Convertible Bonds
에이프로젠바이오로직스
003060
Signal Score
Historical Avg Return (5d)
+0.72%
Data Coverage
100%n=2249
Risk-adjusted indicator based on 2249 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Put Option: Exercisable from December 4, 2027
- • 1st Put Option Rate: 103.0760% (December 4, 2027)
1 more figures — Starter & Pro plans
AI Analysis Summary
Aprogen Biologics Inc. has decided to issue convertible bonds. While specific financial figures for the bond issuance (total amount, conversion price, number of shares) are not provided in this report, the disclosure details the terms of the bondholders' put option. The put option is exercisable from December 4, 2027, with an initial put option rate of 103.0760%, increasing to 105.7834% by March 4, 2029. The issuance of convertible bonds typically implies potential future dilution for existing shareholders, which is generally a negative signal, although the exact impact cannot be quantified without the bond's principal amount and conversion price.
Risk Factors
Pro plan
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Price reaction & historical pattern data
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.